Category Archives: iPrEx OLE

  1. Meet Pedro – A Friendly Rectal Microbicide Advocate

    Check out this interesting mini-bio of Pedro Goicochea, the latest in IRMA’s “Meet a Friendly Rectal Microbicide Advocate” series on the IRMA website here.  Pedro is one of six new bios just posted today, including individuals from Kenya,Thailand and the US.  Each will be featured on the blog, and you can read all of them here right Read More >>

    circumcision, gay men, HIV, hiv prevention, iPrEx, iPrEx OLE, IRMA, IRMA ALC, Meet a Friendly Rectal Microbicide Advocate, Microbicides, MSM, MTN, Peru, rectal microbicide, transgendered, Truvada
  2. Open-Label Extension of iPrEX HIV PrEP Study Begins at 11 Sites in 6 Countries

    Via iPrEX News. The iPrEx Open-Label Extension Study (iPrEx OLE), the next phase of the first human study to report efficacy results on pre-exposure prophylaxis (PrEP) to prevent HIV infection, has begun at clinical trial sites around the world. Approximately 2,000 men and transgender women who have sex with men are expected to participate in the 72-week Read More >>

    Africa, FEM-PrEP, HIV, iPrEx, iPrEx OLE, new prevention technologies, Partners PrEP, prevention, TDF2, Treatment